Health ยท Uganda

Serum Institute to Produce Ebola Vaccine for Uganda

The Serum Institute is to produce an Ebola vaccine for Uganda. The available information does not say which vaccine is involved, how many doses are planned, when production will begin or who made the arrangement, so this account is limited to the announcement itself.

The Serum Institute is set to produce an Ebola vaccine for Uganda, according to a headline that is the only material available on the development.

The available information does not say which Ebola vaccine will be manufactured, or which strain of the virus it is designed to target. It also gives no figures for the number of doses, the value or terms of the arrangement, or the timetable for production and delivery.

It is not stated who agreed the arrangement with the manufacturer, whether the Ugandan government, a health agency or another partner is involved, or whether the vaccine would be used in clinical trials, routine immunisation or an outbreak response. Nor is there any detail on regulatory approval or on how the doses would be distributed once produced.

Because of these gaps, this account is confined to the stated fact that the Serum Institute will make an Ebola vaccine for Uganda. Further details, including the timing of the announcement, the scope of the agreement and any official comment, will need to be confirmed from additional reporting or statements from the parties involved.

More reporting from Voice of Africans